Surendra Karki։ Examining Blood Type and Coronary Heart Disease Risk in Australian Donors
Surendra Karki, Adjunct Senior Lecturer at Monash University, Adjunct Lecturer at the UNSW School of Public Health and Community Medicine, and Research Fellow at Australian Red Cross Lifeblood, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share our new publication in Transfusion!
Our study examined over 32,000 Australian blood donors and found a borderline higher risk of coronary heart disease (CHD) among people with blood group AB, compared with group O. Similar results have also been reported in other populations in other countries.
Please note that in our another published study we have shown the act of blood donation itself has no impact on risk of cardiovascular diseases.
A big thank‑you to our collaborators Katy Bell Rena Hirani, Marijke Welvaert David Irving and the 45 and Up Study participants and donors who made this work possible.
Given ABO blood-group is genetically determined, our recommendation for blood donors and others remains to advise regardless of blood type, to follow healthy lifestyle interventions, including not smoking, participating in regular physical activity, having healthy diets, and making regular general practitioner visits to reduce risk of cardiovascular diseases.”
Title: Association of ABO blood group and coronary heart disease in blood donors—Results from a cohort study in Australia
Authors: Surendra Karki, Katy Bell, David O. Irving, Marijke Welvaert, Rena Hirani
Read the Full Article on Transfusion
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc
-
Jun 24, 2026, 15:40Annette Bowyer: The Emerging Role of Extravascular Factor VII in Haemostasis
-
Jun 24, 2026, 13:50Tijjani Balas: Why Early Detection of DVT Matters
-
Jun 24, 2026, 13:43Brandon Michael Henry: Interpreting Complement Activation After AAV Gene Therapy
-
Jun 24, 2026, 13:37Heba Youssef: Heparin-Induced Thrombocytopenia – The Prothrombotic Emergency You Cannot Miss
-
Jun 24, 2026, 13:32Jecko Thachil: Understanding the Clinical Spectrum of Vitamin B12
-
Jun 24, 2026, 13:32Namrata Singh: Beyond Low Platelets – Understanding What Triggers ITP